Facial nerve palsy associated with atomoxetine-induced hypertension
Sign Up to like & getrecommendations! Published in 2019 at "Brain and Development"
DOI: 10.1016/j.braindev.2018.09.009
Abstract: BACKGROUND Peripheral facial nerve palsy is characterized by unilateral facial paresis due to ipsilateral facial nerve dysfunction. Most cases are idiopathic; however, some have specific etiologies, such as herpesvirus infection, immunological disorders, and hypertension. Atomoxetine… read more here.
Keywords: nerve palsy; palsy; atomoxetine; facial nerve ... See more keywords
ATOMOXETINE FOR HOARDING DISORDER: A PRECLINICAL AND CLINICAL INVESTIGATION
Sign Up to like & getrecommendations! Published in 2017 at "European Neuropsychopharmacology"
DOI: 10.1016/j.euroneuro.2016.07.016
Abstract: Purpose of the study Hoarding disorder is a mental disorder that has been newly included in the DSM-5 into the obsessive-compulsive and related disorders chapter. To date only two open studies investigated the pharmacological management… read more here.
Keywords: disorder; treatment; investigation; atomoxetine ... See more keywords
Atomoxetine-Related Trichotillomania in a Boy with Attention-Deficit/Hyperactivity Disorder.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of child and adolescent psychopharmacology"
DOI: 10.1089/cap.2017.0113
Abstract: Trichotillomania (TTM) is an impulse control disorder characterized by hair pulling and marked hair loss. We describe a case of TTM developing starting atomoxetine with a diagnosis of attention-deficit/hyperactivity disorder (ADHD). An 11-year-old male patient… read more here.
Keywords: deficit hyperactivity; hyperactivity disorder; atomoxetine; attention deficit ... See more keywords
The Role of Atomoxetine for Parkinson Disease–Related Executive Dysfunction: A Systematic Review
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000000963
Abstract: Background Atomoxetine selectively inhibits the reuptake of norepinephrine. Given the noradrenergic system's role in executive function, pharmacotherapy options that affect norepinephrine are of particular clinical interest in Parkinson disease–related executive dysfunction. Objective The aim of… read more here.
Keywords: atomoxetine; executive dysfunction; dysfunction; parkinson disease ... See more keywords
Effect of CYP2D6 and CYP2C19 genotypes on atomoxetine serum levels - a study based on therapeutic drug monitoring data.
Sign Up to like & getrecommendations! Published in 2023 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15706
Abstract: AIM Atomoxetine is mainly metabolized by CYP2D6 while CYP2C19 plays a secondary role. It is known that patients carrying genotypes encoding decreased/absent CYP2D6 metabolism obtain higher atomoxetine concentrations and are at increased risk of adverse… read more here.
Keywords: atomoxetine; cyp2d6 cyp2c19; cyp2c19; therapeutic drug ... See more keywords
The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
Sign Up to like & getrecommendations! Published in 2019 at "American journal of respiratory and critical care medicine"
DOI: 10.1164/rccm.201808-1493oc
Abstract: Rationale: There is currently no effective pharmacological treatment for obstructive sleep apnea (OSA). Recent investigations indicate that drugs with noradrenergic and antimuscarinic effects improve genioglossus muscle activity and upper airway patency during sleep. Objectives: We… read more here.
Keywords: placebo; oxybutynin; severity; obstructive sleep ... See more keywords
Efficacy of Addition of Atomoxetine to Speech Therapy in Stuttering Severity of Children Aged 4-12 Years: A Double-Blind Randomized Controlled Trial
Sign Up to like & getrecommendations! Published in 2022 at "Iranian Journal of Child Neurology"
DOI: 10.22037/ijcn.v16i3.34450
Abstract: Objectives Stuttering is a common problem at all ages that is required to be treated since childhood. Atomoxetine is currently used for the treatment of attention deficit hyperactivity disorder (ADHD). It can be effective for… read more here.
Keywords: stuttering severity; atomoxetine; neurology; severity ... See more keywords